Caspofungin Population Pharmacokinetic Analysis in Plasma and Peritoneal Fluid in Septic Patients with Intra-Abdominal Infections: A Prospective Cohort Study.
Nicolas GarbezLitaty C MbatchiSteven C WallisLaurent MullerJeffrey LipmanJason Alexander RobertsJean-Yves LefrantClaire RogerPublished in: Clinical pharmacokinetics (2021)
There is moderate penetration of caspofungin into the peritoneal cavity (33%). For empirical treatment, a dose escalation of 100 mg loading dose on the first day is suggested for higher FFM to ensure adequate concentrations into the abdominal cavity for the most susceptible candida species.